Vaccine or not?

That converts to a 91% vaccine effectiveness against severe disease.

You can’t convert anything with the numbers given in the tweet. All you get is there are 17% unvaccinated and they make up 70% of an arbitrary , unknown condition. However that does mean the vaccinated make up the rest which is 30%.
 
You can’t convert anything with the numbers given in the tweet. All you get is there are 17% unvaccinated and they make up 70% of an arbitrary , unknown condition. However that does mean the vaccinated make up the rest which is 30%.
The tweet links the article from hareetz that gives the numbers on severe or serious disease. Israel defines serious disease similar to how the US defines severe disease except their oxygen cutoff is a bit more strenuous I believe (under 90% on room air) than US though might be wrong on that.
 
The tweet links the article from hareetz that gives the numbers on severe or serious disease. Israel defines serious disease similar to how the US defines severe disease except their oxygen cutoff is a bit more strenuous I believe (under 90% on room air) than US though might be wrong on that.

And no matter that still leaves 30% of the vaccinated that fall into that category.
 
And no matter that still leaves 30% of the vaccinated that fall into that category.
Yes, that tends to happen when you have a population with >90% vaccination rate among high risk individuals including those over the age of 60 with a vaccine that has 91% vaccine effectiveness
 
  • Like
Reactions: Orangeslice13
Yes, that tends to happen when you have a population with >90% vaccination rate among high risk individuals including those over the age of 60 with a vaccine that has 91% vaccine effectiveness

Now you’re throwing random categories out to try and further narrative the narrative.
 
And yet not approved by the manufacturer so they can’t be sued. I’m all for it if you think it helps. It still hasn’t been studied for prolonged treatment but it isn’t hurting me if you take it.
What makes that different than the vaccines?
And just to be clear, they are referring to dexamethasone in the early part of the article. They don't get to Ivemectin until the middle section.


Here are more human studies from other countries on the 'horse dewormer':

Peru:
  • Sharp Reductions in COVID-19 Case Fatalities and Excess Deaths in Peru in Close Time Conjunction, State-By-State, with Ivermectin Treatments (source, peer-reviewed, University of Toronto, Universidad EAFIT)
For the 24 states with early IVM treatment (and Lima), excess deaths dropped 59% (25%) at +30 days and 75% (25%) at +45 days after day of peak deaths. Case fatalities likewise dropped sharply in all states but Lima
Spain:
  • The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial (source, University of Barcelona, peer-reviewed)
Findings: Patients in the ivermectin group recovered earlier from hyposmia/anosmia (76 vs 158 patient-days; p < 0.001).
Bengladesh:
  • A Comparative Study on Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin Therapy on COVID-19 Patients (source - peer reviewed, though not govt funded)
Conclusion: According to our study, the Ivermectin-Doxycycline combination therapy has better symptomatic relief, shortened recovery duration, fewer adverse effects, and superior patient compliance compared to the Hydroxychloroquine-Azithromycin combination. Based on this study's outcomes, the Ivermectin-Doxycycline combination is a superior choice for treating patients with mild to moderate COVID-19 disease.
  • A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness (source, peer-reviewed double blind randomized, though small sample size)
Discussion: A 5-day course of ivermectin resulted in an earlier clearance of the virus compared to placebo (p = 0.005), thus indicating that early intervention with this agent may limit viral replication within the host. In the 5-day ivermectin group, there was a significant drop in CRP and LDH by day 7, which are indicators of disease severity.
 
What makes that different than the vaccines?
And just to be clear, they are referring to dexamethasone in the early part of the article. They don't get to Ivemectin until the middle section.


Here are more human studies from other countries on the 'horse dewormer':

Peru:
  • Sharp Reductions in COVID-19 Case Fatalities and Excess Deaths in Peru in Close Time Conjunction, State-By-State, with Ivermectin Treatments (source, peer-reviewed, University of Toronto, Universidad EAFIT)
For the 24 states with early IVM treatment (and Lima), excess deaths dropped 59% (25%) at +30 days and 75% (25%) at +45 days after day of peak deaths. Case fatalities likewise dropped sharply in all states but Lima
Spain:
  • The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial (source, University of Barcelona, peer-reviewed)
Findings: Patients in the ivermectin group recovered earlier from hyposmia/anosmia (76 vs 158 patient-days; p < 0.001).
Bengladesh:
  • A Comparative Study on Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin Therapy on COVID-19 Patients (source - peer reviewed, though not govt funded)
Conclusion: According to our study, the Ivermectin-Doxycycline combination therapy has better symptomatic relief, shortened recovery duration, fewer adverse effects, and superior patient compliance compared to the Hydroxychloroquine-Azithromycin combination. Based on this study's outcomes, the Ivermectin-Doxycycline combination is a superior choice for treating patients with mild to moderate COVID-19 disease.

  • A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness (source, peer-reviewed double blind randomized, though small sample size)
Discussion: A 5-day course of ivermectin resulted in an earlier clearance of the virus compared to placebo (p = 0.005), thus indicating that early intervention with this agent may limit viral replication within the host. In the 5-day ivermectin group, there was a significant drop in CRP and LDH by day 7, which are indicators of disease severity.
Doesn’t to me.
Seems to be a problem in relation to the vaccine though.
I guess it just depends on your narrative.
I’ve said 100 times that you should be allowed to take it if you want.
 

VN Store



Back
Top